Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its α receptor by Francesco De.

Slides:



Advertisements
Similar presentations
Volume 56, Issue 5, Pages (November 1999)
Advertisements

Volume 140, Issue 2, Pages e9 (February 2011)
Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial Cells  Rosalba Salcedo, Ken Wasserman,
Cell Physiol Biochem 2016;40: DOI: /
Volume 132, Issue 1, Pages (January 2007)
Volume 133, Issue 1, Pages (July 2007)
Corresponding author:
Platelet-Derived Growth Factor-BB Mediates Cell Migration through Induction of Activating Transcription Factor 4 and Tenascin-C  Kristine P. Malabanan,
Molecular Therapy - Oncolytics
Hon-Wai Koon, Dezheng Zhao, Hua Xu, Collin Bowe, Alan Moss, Mary P
by Richard C. A. Sainson, Douglas A. Johnston, Henry C. Chu, Matthew T
by Matilde Murga, Oscar Fernandez-Capetillo, and Giovanna Tosato
Involvement of suppressors of cytokine signaling in toll-like receptor–mediated block of dendritic cell differentiation by Holger Bartz, Nicole M. Avalos,
Functional analysis of the cytoplasmic domain of the integrin α1 subunit in endothelial cells by Tristin D. Abair, Nada Bulus, Corina Borza, Munirathinam.
by Jonathan M. Gleadle, and Peter J. Ratcliffe
PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway
PRT , a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model by Michael P. Reilly, Uma Sinha,
Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production by Yeon-Sook Choi, Hyun-Jung.
Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis by Hajime.
Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-κB and c-Jun N-terminal kinase by Ingrid Pollet, Christy.
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways by Gilles Despouy, Marjorie Joiner, Emilie Le Toriellec,
Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1 by Ingrid G. Winkler,
by Rafijul Bari, Teresa Bell, Wai-Hang Leung, Queenie P
by Cornelia Halin, Nadja E. Tobler, Benjamin Vigl, Lawrence F
by Fawzi Aoudjit, and Kristiina Vuori
Lipopolysaccharide Activates Caspase-1 (Interleukin-1–Converting Enzyme) in Cultured Monocytic and Endothelial Cells by Ralf R. Schumann, Claus Belka,
Volume 133, Issue 1, Pages (July 2007)
Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in.
Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways by Chang Min Yoon, Bok Sil Hong, Hyung Geun Moon,
by Rong L. He, Jian Zhou, Crystal Z
by Veerendra Munugalavadla, Jovencio Borneo, David A
Downstream effectors of oncogenic ras in multiple myeloma cells
Volume 21, Issue 6, Pages (December 2004)
by Norman Nausch, Ioanna E
Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1β and Interleukin-6 From Bone Marrow Macrophages by Sophia.
Volume 132, Issue 1, Pages (January 2007)
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression by Rosalba Salcedo, Maria Lourdes.
Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration by Michel Ticchioni, Céline Charvet, Nelly Noraz, Laurence Lamy,
by Juan M. Cárcamo, Oriana Bórquez-Ojeda, and David W. Golde
by Jun Yuan, David B. Lovejoy, and Des R. Richardson
Vascular endothelial growth factor stimulates protein kinase CβII expression in chronic lymphocytic leukemia cells by Simon T. Abrams, Benjamin R. B. Brown,
Regulation of tumor angiogenesis by integrin-linked kinase (ILK)
Volume 66, Issue 5, Pages (November 2004)
Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3)‏ by Tamar Licht, Lilia Tsirulnikov,
Volume 131, Issue 5, Pages (November 2006)
Volume 140, Issue 2, Pages e9 (February 2011)
Volume 56, Issue 5, Pages (November 1999)
Volume 131, Issue 5, Pages (November 2006)
Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro.
Volume 64, Issue 2, Pages (August 2003)
Volume 68, Issue 1, Pages (July 2005)
Volume 135, Issue 2, Pages e2 (August 2008)
Inhibition of β-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non–small-cell Lung Cancer with a T790M Mutation  Yosuke.
Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI 3-kinase and ERK  Richard J. Dixon, Nigel J. Brunskill 
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor  L.D. Alexander, Y. Ding, S. Alagarsamy,
Sema4D, the Ligand for Plexin B1, Suppresses c-Met Activation and Migration and Promotes Melanocyte Survival and Growth  Joanne Soong, Yulin Chen, Elina.
Volume 64, Issue 1, Pages (July 2003)
Inhibition of β-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non–small-cell Lung Cancer with a T790M Mutation  Yosuke.
Volume 6, Issue 4, Pages (October 2004)
Volume 16, Issue 12, Pages (June 2006)
Volume 15, Issue 1, Pages (January 2009)
TIMP-2 Mediated Inhibition of Angiogenesis
Corticotropin-Releasing Hormone Stimulates Angiogenesis and Epithelial Tumor Growth in the Skin  Jack L. Arbiser, Katia Karalis, Akila Viswanathan, Chieko.
Green Tea Polyphenol Epigallocatechin-3-Gallate Suppresses Collagen Production and Proliferation in Keloid Fibroblasts via Inhibition of the STAT3-Signaling.
Volume 21, Issue 6, Pages (December 2004)
Volume 60, Issue 3, Pages (September 2001)
Carole A. Perruzzi, Mary C. Whelan, Donald R. Senger 
Molecular Therapy - Oncolytics
The adaptor protein Lad associates with the G protein β subunit and mediates chemokine-dependent T-cell migration by Dongsu Park, Inyoung Park, Deogwon.
Presentation transcript:

Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its α receptor by Francesco De Marchis, Domenico Ribatti, Claudia Giampietri, Alessandro Lentini, Debora Faraone, Marco Scoccianti, Maurizio C. Capogrossi, and Antonio Facchiano Blood Volume 99(6):2045-2053 March 15, 2002 ©2002 by American Society of Hematology

BAEC migration in the presence of bFGF and PDGF-BB BAEC migration in the presence of bFGF and PDGF-BB.(A) BAEC migration was examined in response to increasing concentrations of PDGF-BB alone (dashed line) or increasing concentrations of PDGF-BB in the presence of 10 ng/mL bFGF (continuous line). BAEC migration in the presence of bFGF and PDGF-BB.(A) BAEC migration was examined in response to increasing concentrations of PDGF-BB alone (dashed line) or increasing concentrations of PDGF-BB in the presence of 10 ng/mL bFGF (continuous line). The bFGF effect was strongly inhibited by PDGF-BB in a dose-dependent manner. (inset) Denatured PDGF-BB did not show any inhibitory effect. (B) BAEC migration was examined in response to increasing concentrations of bFGF alone (dashed line) or increasing concentrations of bFGF in the presence of 10 ng/mL PDGF-BB (continuous line). The bFGF effect was strongly inhibited by PDGF-BB at all concentrations. Data are expressed as average ± SD of 4 experiments carried out in duplicate. Francesco De Marchis et al. Blood 2002;99:2045-2053 ©2002 by American Society of Hematology

BAEC proliferation in the presence of bFGF and PDGF-BB BAEC proliferation in the presence of bFGF and PDGF-BB.BAEC proliferation was evaluated in response to 0.1% BSA, bFGF alone (10 ng/mL), PDGF-BB alone (10 ng/mL), or bFGF/PDGF-BB (10 ng/mL each). BAEC proliferation in the presence of bFGF and PDGF-BB.BAEC proliferation was evaluated in response to 0.1% BSA, bFGF alone (10 ng/mL), PDGF-BB alone (10 ng/mL), or bFGF/PDGF-BB (10 ng/mL each). The bFGF mitogenic effect was lowered to control levels in the presence of PDGF-BB. Data are expressed as average ± SD of 4 experiments carried out in duplicate. Francesco De Marchis et al. Blood 2002;99:2045-2053 ©2002 by American Society of Hematology

BAEC differentiation into tubular structures on Matrigel BAEC differentiation into tubular structures on Matrigel.BAEC differentiation on Matrigel-coated wells in the presence of (A) 0.1% BSA, (B) 1% FCS, (C) 10 ng/mL bFGF, (D) 10 ng/mL PDGF-BB, or (E) 10 ng/mL bFGF/PDGF-BB. BAEC differentiation into tubular structures on Matrigel.BAEC differentiation on Matrigel-coated wells in the presence of (A) 0.1% BSA, (B) 1% FCS, (C) 10 ng/mL bFGF, (D) 10 ng/mL PDGF-BB, or (E) 10 ng/mL bFGF/PDGF-BB. (F) Quantification of branching points was carried out on 10 fields. The differentiation effect of bFGF was lowered to control levels in the presence of PDGF-BB. This effect was evident at 3, 6, 8, and 24 hours. Figures and the bar graph refer to the effect at 3 hours. Experiments were carried out 3 times in duplicate. Panels A to E refer to a representative experiment. Francesco De Marchis et al. Blood 2002;99:2045-2053 ©2002 by American Society of Hematology

BAEC migration in the presence of PDGF-AA BAEC migration in the presence of PDGF-AA.BAEC migration in response to PDGF-BB or bFGF, alone or in combination (10 ng/mL), was examined in the absence and in the presence of PDGF-AA (10 ng/mL). BAEC migration in the presence of PDGF-AA.BAEC migration in response to PDGF-BB or bFGF, alone or in combination (10 ng/mL), was examined in the absence and in the presence of PDGF-AA (10 ng/mL). PDGF-AA showed no chemotactic effect on BAEC, but it inhibited bFGF-induced migration, and the magnitude of this effect was comparable to that of an equal concentration of PDGF-BB. Data are expressed as average ± SD of 3 experiments carried out in duplicate. Francesco De Marchis et al. Blood 2002;99:2045-2053 ©2002 by American Society of Hematology

Migration of BAECs transfected with dominant-negative receptors Migration of BAECs transfected with dominant-negative receptors.BAECs were transfected either with a dominant-negative PDGF-Rα vector (DN-PDGF-Rα), with a dominant-negative PDGF-Rβ vector (DN-PDGF-Rβ, or with a PcDNA3 empty vector and were cotransfected wit... Migration of BAECs transfected with dominant-negative receptors.BAECs were transfected either with a dominant-negative PDGF-Rα vector (DN-PDGF-Rα), with a dominant-negative PDGF-Rβ vector (DN-PDGF-Rβ, or with a PcDNA3 empty vector and were cotransfected with pEGFP-N1 reporter vector. A dominant-negative versus reporter-vector molar ratio of 4:1 was used. Under these conditions both plasmids were internalized in the same cell; when migrated cells were examined, only GFP-positive cells were counted. Neither the empty vector nor the dominant-negative vectors affected bFGF-induced migration. PDGF-BB inhibitory effect on bFGF-induced migration was present in the empty-vector–transfected cells and in the DN-PDGF-Rβ–transfected cells, whereas it was absent in DN-PDGF-Rα–transfected cells. In the latter, BAEC migration was increased in the presence of PDGF-BB and bFGF compared with bFGF alone. *Statistically significant difference (P < .01). Data are expressed as average ± SD of 4 experiments carried out in duplicate. Francesco De Marchis et al. Blood 2002;99:2045-2053 ©2002 by American Society of Hematology

PDGF receptor phosphorylation and MAP kinase activation PDGF receptor phosphorylation and MAP kinase activation.(A) PDGF receptor phosphorylation was investigated at 5-minute PDGF-BB exposure (10 ng/mL), with or without bFGF. PDGF receptor phosphorylation and MAP kinase activation.(A) PDGF receptor phosphorylation was investigated at 5-minute PDGF-BB exposure (10 ng/mL), with or without bFGF. Increased phosphorylation of PDGF-Rα and PDGF-Rβ was found in the presence of bFGF/PDGF-BB compared with PDGF-BB alone (average increase, 52% ± 18%). Anti–PDGF-BB neutralizing antibody (Ab-PDGF-BB) markedly inhibited PDGF receptor phosphorylation. This experiment was carried out 3 times with similar results. One representative experiment is shown. (B) Phosphorylation of PDGF-Rα was investigated in BAECs exposed to PDGF-AA, which is a PDGF-Rα–specific agonist, in the absence and in the presence of bFGF. Under these conditions, bFGF/PDGF-AA–treated cells showed increased phosphorylation compared with PDGF-AA alone. Receptor phosphorylation was markedly reduced in DN-PDGF-Rα–transfected cells. This experiment was carried out 3 times, with similar results. One representative experiment is shown. (C) ERK1/2 phosphorylation induced by bFGF alone, PDGF-BB alone, and bFGF/PDGF-BB was detected with an antibody specifically recognizing the activated forms at 44 kd and 42 kd, respectively. A marked phosphorylation decrease was found in the presence of bFGF/ PDGF-BB compared with bFGF alone. This experiment was carried out 5 times with similar results. One representative experiment is shown. Francesco De Marchis et al. Blood 2002;99:2045-2053 ©2002 by American Society of Hematology

Macroscopic observations of the PDGF-AA and PGDF-BB effect on bFGF-induced neovascularization in the CAM assay.Gelatin sponge adsorbed with bFGF (500 μg) is surrounded by allantoic vessels that develop radially toward the implant in a spoked-wheel pattern (... Macroscopic observations of the PDGF-AA and PGDF-BB effect on bFGF-induced neovascularization in the CAM assay.Gelatin sponge adsorbed with bFGF (500 μg) is surrounded by allantoic vessels that develop radially toward the implant in a spoked-wheel pattern (A), whereas no vascular reaction is detectable around PBS-treated (B) and PDGF-AA–treated (C) sponges. Allantoic vessels were less numerous in the specimens treated with bFGF added to PDGF-AA and PDGF-BB (500 μg each) (D and F, respectively), whereas PDGF-BB alone induced a moderate angiogenic response (E). Asterisks indicate sponges. Panels refer to a representative experiment. Original magnification, × 50. Francesco De Marchis et al. Blood 2002;99:2045-2053 ©2002 by American Society of Hematology

Angiogenesis in Matrigel assay Angiogenesis in Matrigel assay.Angiogenesis was measured in Matrigel plugs injected subcutaneously in CD1 mice. Angiogenesis in Matrigel assay.Angiogenesis was measured in Matrigel plugs injected subcutaneously in CD1 mice. Matrigel was added with bFGF (150 ng/mL), PDGF-BB (150 ng/mL), or both. The bFGF-induced vessel formation was significantly reduced in the presence of PDGF-BB. Data were collected on 8 animals for bFGF alone, 6 animals for PDGF-BB alone, 11 animals for bFGF/PDGF-BB treatment, and 8 animals for negative controls. Data are expressed as average ± SD. Francesco De Marchis et al. Blood 2002;99:2045-2053 ©2002 by American Society of Hematology